Laboratory Compliance

Access to cloud-based platform during COVID-19 pandemic For pathologists and scientists who are working from home, and to enable remote working for those who are not currently able to practice social distancing measures due to a lack of...

FDA’s Enforcement Discretion Allowing Use of ImageScope DX Viewing Software for Remote Diagnosis During COVID-19 Emergency Your safety is very important to us at Leica Biosystems. We are pleased to inform you that Aperio ImageScope DX with...

Inspirata gains strategic support in its initiative to allow pathology departments across the world to offer work-from-home opportunities for their pathologists during the COVID-19 pandemic crisis. Tampa, Florida (GLOBE NEWSWIRE) -- Cancer...

Linköping, Sweden and Shelton, CT – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received a 510(k) clearance by the US Food & Drug Administration (FDA). The clearance applies for Sectra Digital...

Leica Biosystems, the global leader in pathology workflow solutions, announced it has received notification from the U.S. Food & Drug Administration (FDA) that its Aperio ImageScope DX Viewer with images acquired on the Aperio AT2 DX...

The CAP has aggressively urged the Centers for Medicare & Medicaid Services (CMS) to allow pathologists and laboratory personnel to work remotely during the COVID-19 national emergency. Also, the CAP has engaged with Congress to support...